For instance, Kallikrein genes retaining intron III lose enzymatic activity in prostate cancer, and the intron III-retaining kallikrein-15 variant emerges as a potential biomarker for prostate cancer [63]. The gene discussed is KLK4; the disease is Familial prostate cancer.